Scientific Committee
Julien Boutet is an experienced Chemist with more than 15 years’ experience in R&D mainly as R&D manager and Project manager in different areas: chemistry, biocatalysis and biotechnology processes ; mainly for process scale-up from laboratory to industrial scale.
He holds a Ph.D. in Glyco-chemistry at Institut Pasteur from Paris Descartes University. From 2008 to 2013, he served as project manager for the scale-up of HMOs (Human Milk Oligosaccharides) at Glycom A/S then joined Adisseo, world leaders in animal nutrition, to set-up a R&D center in France and then in China. In 2019, he joined Seqens and became Innovation Director to promote transversality, cross-fertilization, ideas generation from their generation to business opportunities (technologies and products). Recently he became Biotechnologies Director at Seqens, leading a team of 25+ people with management of two entities Protéus and Alganelle. One of the key missions is to become a PRDO (Partnerships Research and Development Organization) with a dual model: R&D services and new products development thanks to co-development model.
Inventor/author of over 30 patents and 15 publications
https://www.linkedin.com/in/julien-boutet-5a25a742/?locale=en_US
ANTHONY BRESIN
Founder of AnBreiL
Anthony Bresin has more than 25 years of experience in the industrial biotechnology field, with expertise spanning fermentation, purification, and process scale-up from laboratory to industrial manufacturing.
He holds a Ph.D. in Industrial Fermentation on hyaluronic acid production from Reims Champagne-Ardenne University (France).
From 2000 to 2018, he served at ARD (Agro-Industrie Recherches et Développements, France), where he successively held scientific and managerial positions, ultimately as Chief Scientific Officer and Head of R&D. During this period, he led programs in fermentation, fractionation, and biopolymer development, contributing to the creation and industrialization of new bio-based molecules and polymers.
He then joined HTL (2018–2023) as Chief R&D and Validation Officer, overseeing R&D programs and technology transfers focused on biopolymers such as hyaluronic acid.
Since 2023, he has been leading AnBreiL, a biotechnology advisory firm providing scientific and strategic support in R&D, process development, and scale-up for companies active in biopolymers and fermentation-derived products.
Professor François Coutte is a professor of microbiology and molecular biology at the University of Lille, France. He obtained his PhD in biotechnology and was accredited to supervise research at the University of Lille in 2009 and 2019, respectively. Since 2010, Professor Coutte has been conducting research on the production of secondary metabolites of microbial origin at UMRt INRAE 1158 BioEcoAgro. He specialises in microbial culture processes for the production of metabolites of interest. His research focuses mainly on lipopeptides derived from Bacillus and Pseudomonas, and in particular on the various genetic, metabolic and bioprocess engineering strategies that enable their overproduction and the development of their applications. Thanks to this research, he has participated in numerous collaborative research projects at European level (H2020, INTERREG, BBI). He has also promoted and transferred part of this work to an industrial scale through the creation of the company Lipofabrik. He is currently co-director of the VALOREEMA industrial chair, which focuses on the valorisation of agricultural resources through extraction, biocatalysis or fermentation.
Nathalie Gorret is an INRAE Research Scientist at Toulouse Biotechnology Institute (TBI UMR CNRS INSA 5504 INRAe 792) since 2007. For 18 years, she developed her research within the Group Fermentation Advances and Microbial Engineering (FAME) and recently joined and co-leads the group PHYGE (Physiologie intégrée et génomique fonctionnelle des systèmes microbiens et des champignons filamenteux). Her pHD followed by a 3 years post-doctorate at MIT (Massachusetts Institute of Technology, Cambridge, USA) in Pr Sinskey’Lab (Biology Department) have contributed to developing expertise in Microbial Physiology and Biochemical Engineering, working with bacteria, yeast and plant cells for various biotechnology applications.
She joined Toulouse Biotechnology Institute in 2005 as a post-doctoral fellow to investigate the dynamics of the interaction between biological and physical phenomena observed in large-scale bioreactor. Since then, her researches focus on the understanding of the impact of heterogeneities (substrates/products/pH/dissolved oxygen/sub-populations) on the microbial behavior and strain robustness at both population and sub-population levels (physiological states / morphological states / genetic stability) using Wild Type and genetically modified strains in order to optimize microbial processes. She developed skills on methodologies and tools to characterize and quantify the transient microbial responses to environmental stresses using offline and online biosensors at both global population and single-cell levels. In addition, she develops projects focusing more specifically on biochemical engineering and the development and optimization of bioprocesses, implementing unconventional microorganisms (extremophile microorganism for example) or for specific bioproductions such as Single Cell Proteins (SCP) and lipids.
Professor Marcin Łukaszewicz (University of Wrocław/Wrocław University of Economics and Business / InventionBio) is a biotechnologist working at the interface of industrial microbiology, bioprocess engineering and the circular bioeconomy. He obtained his PhD in Applied Natural Sciences at Université catholique de Louvain (Belgium), followed by habilitation in biology, and received the title of full professor in Poland (2019).
His research and innovation activities focus on microbial biosurfactants, particularly lipopeptide biosurfactants, biotransformation and valorisation of agro‑food industry by‑products, and anaerobic digestion/methanogenesis, including the development of resources such as the PhyMet2 toolkit for methanogens https://phymet2.biotech.uwr.edu.pl/?ind=about
In parallel, he is the CEO and co‑founder of InventionBio S.A. www.inventionbio.pl, developing sustainable, waste‑free biorefinery solutions based on ferrmentation with GRAS microorganisms with applications across cosmetics, animal nutrition and biofertilisers. He is also interested in continuous, cost‑efficient biosurfactant production, closed‑loop media utilisation, and applying the EFQM Excellence Model to R&D project management to increase project success rates.
Pierre Monsan (77) est Professeur émérite à l’INSA, Université de Toulouse et ancien professeur de l’Ecole des Mines ParisTech (1993-2016). Il est membre de conseils d’administration et de conseils scientifiques d’entreprises. Il est membre Senior de l’Institut universitaire de France (2003-2013). Il a créé en 2012 le démonstrateur préindustriel « Toulouse White Biotechnology » (UMS INRA/INSA/CNRS), doté de 20 M€ par l’ANR. Il a été directeur général de la société Cell-Easy (Campus Santé du Futur, Toulouse), CDMO spécialisée dans le domaine des Biothérapies (2019-2024). Il est co-fondateur des sociétés BioEurope (1984àGroupe Solabia), BioTrade (1996-) et Génibio (1998àGroupe PiLeJe), membre fondateur de l’Académie des Technologies et membre de l’Académie Nationale d’agriculture. Il est membre de l’« Innovation Board » du Ministère bulgare de l’innovation et de la croissance (2020-), membre du « College of Fellows » de l’American Institute for Medical and Biological Engineering (AIMBE), Docteur Honoris Causa de l’Université de Liège (Belgique) et de l’Université de Plovdiv (Bulgarie), Président Honoraire fondateur de la Fédération Française des Biotechnologies, et ancien membre du Conseil Exécutif de la Fédération Européenne de Biotechnologie (EFB). Il a présidé le CCRRDT Midi-Pyrénées (2004-2015). Il est Chevalier du Mérite et de la Légion d’Honneur, et Officier des Palmes Académiques. Son domaine scientifique est celui de la catalyse et de l’ingénierie moléculaire enzymatiques. Il est l’auteur de plus de 250 publications scientifiques, de trois ouvrages et de 65 brevets. Son facteur H est 54. Ses domaines de compétence sont la Biocatalyse, les Biotechnologies industrielles et les Biothérapies.
After an agricultural engineer School in France (Lasalle Beauvais), Alexis RANNOU joined ARD for activities in R&D to extract non digestible sugar for surfactant application (1991-1995). He was after in charge of ARD’s pilot plant (1995-1997).
In 1997 he joined the Soliance company (daughter company of ARD) as technical director.
In 2000 he was named as Deputy General Manager in charge of the industrial production.
In 2007 he was in charge of the innovation team and several global accounts.
In 2014 he joined Givaudan as Operations Director & site manager
Since 2018, he held the position of Head of Operations Strategy in charge of tolling & process development for Givaudan Active Beauty
Elodie Wattez is specialized in development of new dairy bioactives for animal and human healthcare. After obtaining her master degree of Nutrition and Food Science from Agrosup Rennes, she joined Ingredia RD teams 10 years ago. Nowdays she is Managing and responsible for the INGREDIA’ RD team of the milk cracking and the fermentation for bioactive solutions.
Thanks to a strong network and cooperation with academic struture and/or industrial partner, the team applies the new knowledges from bioactive peptides in order to develop new health ingredients.
The team activities focus on enzymes and/ fermentation processes to produce molecules of interest from lab scale format to industrial scale up in addition to the proof of efficiency towards clinical studies.
